Glanbia plc (OTCMKTS:GLAPY – Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 31st, there was short interest totalling 200 shares, a growth of 100.0% from the March 15th total of 100 shares. Based on an average trading volume of 200 shares, the short-interest ratio is currently 1.0 days. Currently, 0.0% of the shares of the stock are sold short.
Glanbia Stock Down 1.9 %
OTCMKTS GLAPY traded down $1.21 during mid-day trading on Friday, hitting $62.14. The stock had a trading volume of 8 shares, compared to its average volume of 200. The firm’s 50 day moving average is $68.67 and its 200 day moving average is $75.83. The company has a quick ratio of 0.91, a current ratio of 1.63 and a debt-to-equity ratio of 0.40. Glanbia has a twelve month low of $52.40 and a twelve month high of $63.35.
Glanbia Increases Dividend
The firm also recently disclosed a dividend, which will be paid on Monday, May 12th. Shareholders of record on Friday, March 21st will be issued a $1.2109 dividend. This is an increase from Glanbia’s previous dividend of $0.86. The ex-dividend date is Friday, March 21st.
About Glanbia
Glanbia plc, together with its subsidiaries, operates as a nutrition company worldwide. The company offers sports nutrition and lifestyle nutrition products in various formats, such as powders, ready-to-eat bars and snacking food, and ready-to-drink beverage. It also manufactures and sells cheese, dairy, and non-dairy nutritional and functional ingredients; and vitamin and mineral premixes products.
Featured Stories
- Five stocks we like better than Glanbia
- Energy and Oil Stocks Explained
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- There Are Different Types of Stock To Invest In
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Receive News & Ratings for Glanbia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glanbia and related companies with MarketBeat.com's FREE daily email newsletter.